Research Report Identifies Shutterstock, Intra-Cellular Therapies, ConforMIS, Jack Henry & Associates, Instructure, and WEX with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

NEW YORK, Jan. 30, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Shutterstock, Inc. (NYSE:SSTK), Intra-Cellular Therapies Inc. (NASDAQ:ITCI), ConforMIS, Inc. (NASDAQ:CFMS), Jack Henry & Associates, Inc. (NASDAQ:JKHY), Instructure, Inc. (NYSE:INST), and WEX Inc. (NYSE:WEX), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

SSTK DOWNLOAD: http://Fundamental-Markets.com/register/?so=SSTK
ITCI DOWNLOAD: http://Fundamental-Markets.com/register/?so=ITCI
CFMS DOWNLOAD: http://Fundamental-Markets.com/register/?so=CFMS
JKHY DOWNLOAD: http://Fundamental-Markets.com/register/?so=JKHY
INST DOWNLOAD: http://Fundamental-Markets.com/register/?so=INST
WEX DOWNLOAD: http://Fundamental-Markets.com/register/?so=WEX

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Shutterstock, Inc. (NYSE:SSTK), Intra-Cellular Therapies Inc. (NASDAQ:ITCI), ConforMIS, Inc. (NASDAQ:CFMS), Jack Henry & Associates, Inc. (NASDAQ:JKHY), Instructure, Inc. (NYSE:INST), and WEX Inc. (NYSE:WEX) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed January 26th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

SHUTTERSTOCK, INC. (SSTK) REPORT OVERVIEW

Shutterstock's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Shutterstock reported revenue of $141.06MM vs $123.07MM (up 14.62%) and basic earnings per share $0.14 vs $0.27 (down 48.15%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Shutterstock reported revenue of $494.32MM vs $425.15MM (up 16.27%) and basic earnings per share $0.93 vs $0.54 (up 72.22%). Shutterstock is expected to report earnings on February 22nd, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.29. The estimated EPS forecast for the next fiscal year is $0.87 and is expected to report on February 22nd, 2018.

To read the full Shutterstock, Inc. (SSTK) report, download it here: http://Fundamental-Markets.com/register/?so=SSTK

-----------------------------------------

INTRA-CELLULAR THERAPIES INC. (ITCI) REPORT OVERVIEW

Intra-Cellular Therapies' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Intra-Cellular Therapies reported revenue of $0.03MM vs $0.00MM and basic earnings per share -$0.53 vs -$0.70. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Intra-Cellular Therapies reported revenue of $0.33MM vs $0.09MM (up 261.82%) and basic earnings per share -$2.69 vs -$2.91. Intra-Cellular Therapies is expected to report earnings on March 7th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.64. The estimated EPS forecast for the next fiscal year is -$2.40 and is expected to report on March 7th, 2018.

To read the full Intra-Cellular Therapies Inc. (ITCI) report, download it here: http://Fundamental-Markets.com/register/?so=ITCI

-----------------------------------------

CONFORMIS, INC. (CFMS) REPORT OVERVIEW

ConforMIS's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, ConforMIS reported revenue of $18.43MM vs $18.64MM (down 1.17%) and basic earnings per share -$0.29 vs -$0.31. For the twelve months ended December 31st, 2016 vs December 31st, 2015, ConforMIS reported revenue of $79.90MM vs $66.89MM (up 19.45%) and basic earnings per share -$1.39 vs -$2.60. ConforMIS is expected to report earnings on February 7th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.37. The estimated EPS forecast for the next fiscal year is -$1.03 and is expected to report on February 7th, 2018.

To read the full ConforMIS, Inc. (CFMS) report, download it here: http://Fundamental-Markets.com/register/?so=CFMS

-----------------------------------------

JACK HENRY & ASSOCIATES, INC. (JKHY) REPORT OVERVIEW

Jack Henry & Associates' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Jack Henry & Associates reported revenue of $359.93MM vs $345.03MM (up 4.32%) and basic earnings per share $0.82 vs $0.79 (up 3.80%). For the twelve months ended June 30th, 2017 vs June 30th, 2016, Jack Henry & Associates reported revenue of $1,431.12MM vs $1,354.65MM (up 5.65%) and basic earnings per share $3.16 vs $3.13 (up 0.96%). Jack Henry & Associates is expected to report earnings on February 6th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.75. The estimated EPS forecast for the next fiscal year is $3.70 and is expected to report on August 21st, 2018.

To read the full Jack Henry & Associates, Inc. (JKHY) report, download it here: http://Fundamental-Markets.com/register/?so=JKHY

-----------------------------------------

INSTRUCTURE, INC.  (INST) REPORT OVERVIEW

Instructure's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Instructure reported revenue of $42.95MM vs $30.15MM (up 42.47%) and basic earnings per share -$0.42 vs -$0.44. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Instructure reported revenue of $110.88MM vs $73.19MM (up 51.49%) and basic earnings per share -$1.92 vs -$6.07. Instructure is expected to report earnings on February 12th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.46. The estimated EPS forecast for the next fiscal year is -$1.53 and is expected to report on February 12th, 2018.

To read the full Instructure, Inc. (INST) report, download it here: http://Fundamental-Markets.com/register/?so=INST

-----------------------------------------

WEX INC. (WEX) REPORT OVERVIEW

WEX's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, WEX reported revenue of $324.00MM vs $287.76MM (up 12.60%) and basic earnings per share $0.79 vs $0.46 (up 71.74%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, WEX reported revenue of $1,018.46MM vs $854.64MM (up 19.17%) and basic earnings per share $1.49 vs $2.63 (down 43.35%). WEX is expected to report earnings on February 21st, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $1.20. The estimated EPS forecast for the next fiscal year is $5.99 and is expected to report on February 21st, 2018.

To read the full WEX Inc. (WEX) report, download it here: http://Fundamental-Markets.com/register/?so=WEX

-----------------------------------------

ABOUT  FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.